Abpro Holdings, Inc. Warrant (ABPWW)

• 1 day: 0.00%
• 5 days: -1.96%
• 1 month: -22.18%
• 3 months: -51.22%
• 6 months: -66.61%
• Year to date: -75.90%
• 1 year: -71.83%
• 5 years: -90.00%
• 10 years: -90.00%
• Sector: Healthcare
• Industry: Biotechnology

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Employees: 6

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

53% more capital invested

Capital invested by funds: $394K [Q3] → $603K (+$210K) [Q4]

7% less funds holding

Funds holding: 29 [Q3] → 27 (-2) [Q4]

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5